BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 32794657)

  • 1. Analysis of rare variants of autosomal-dominant genes in a Chinese population with sporadic Parkinson's disease.
    Zheng R; Jin CY; Chen Y; Ruan Y; Gao T; Lin ZH; Dong JX; Yan YP; Tian J; Pu JL; Zhang BR
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1449. PubMed ID: 32794657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematically analyzing rare variants of autosomal-dominant genes for sporadic Parkinson's disease in a Chinese cohort.
    Yang N; Zhao Y; Liu Z; Zhang R; He Y; Zhou Y; Xu Q; Sun Q; Yan X; Guo J; Tang B
    Neurobiol Aging; 2019 Apr; 76():215.e1-215.e7. PubMed ID: 30598256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic landscape of Parkinson's disease.
    Lunati A; Lesage S; Brice A
    Rev Neurol (Paris); 2018 Nov; 174(9):628-643. PubMed ID: 30245141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Panel Sequencing Analysis Revealed a Strong Contribution of Rare Coding Variants to the Risk of Parkinson's Disease in Sporadic Moroccan Patients.
    Smaili I; Tibar H; Rahmani M; Machkour N; Razine R; Darai HN; Bouslam N; Benomar A; Regragui W; Bouhouche A
    J Mol Neurosci; 2023 Jun; 73(6):391-402. PubMed ID: 37256495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
    Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V
    Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.
    Di Fonzo A; Wu-Chou YH; Lu CS; van Doeselaar M; Simons EJ; Rohé CF; Chang HC; Chen RS; Weng YH; Vanacore N; Breedveld GJ; Oostra BA; Bonifati V
    Neurogenetics; 2006 Jul; 7(3):133-8. PubMed ID: 16633828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey.
    Kessler C; Atasu B; Hanagasi H; Simón-Sánchez J; Hauser AK; Pak M; Bilgic B; Erginel-Unaltuna N; Gurvit H; Gasser T; Lohmann E
    Parkinsonism Relat Disord; 2018 Mar; 48():34-39. PubMed ID: 29248340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson's disease cohort.
    Bryant N; Malpeli N; Ziaee J; Blauwendraat C; Liu Z; ; West AB
    Hum Mol Genet; 2021 Apr; 30(6):454-466. PubMed ID: 33640967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.
    Wu-Chou YH; Chen YT; Yeh TH; Chang HC; Weng YH; Lai SC; Huang CL; Chen RS; Huang YZ; Chen CC; Hung J; Chuang WL; Lin WY; Chen CH; Lu CS
    Parkinsonism Relat Disord; 2013 Feb; 19(2):251-5. PubMed ID: 23182315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel variants in LRRK2 gene in patients with Parkinson's disease in Serbian population.
    Janković MZ; Kresojević ND; Dobričić VS; Marković VV; Petrović IN; Novaković IV; Kostić VS
    J Neurol Sci; 2015; 353(1-2):59-62. PubMed ID: 25899316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A glimpse of the genetics of young-onset Parkinson's disease in Central Asia.
    Kaiyrzhanov R; Aitkulova A; Vandrovcova J; Murphy D; Zharkinbekova N; Shashkin C; Akhmetzhanov V; Kaishibayeva G; Karimova A; Myrzayev Z; Murray M; Khaibullin T; Hardy J; Houlden H
    Mol Genet Genomic Med; 2021 Jun; 9(6):e1671. PubMed ID: 33818904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative screening for 12 rare LRRK2 pathogenic variants in a cohort of Nigerians with Parkinson's disease.
    Rizig M; Ojo OO; Athanasiou-Fragkouli A; Agabi OP; Oshinaike OO; Houlden H; Okubadejo NU
    Neurobiol Aging; 2021 Mar; 99():101.e15-101.e19. PubMed ID: 33158606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
    Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
    J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of LRRK2 in Parkinson's disease in Han Chinese population.
    Zhang JR; Jin H; Li K; Mao CJ; Yang YP; Wang F; Gu CC; Zhang HJ; Chen J; Liu CF
    Neurobiol Aging; 2018 Dec; 72():187.e5-187.e10. PubMed ID: 30049590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants.
    Xiromerisiou G; Hadjigeorgiou GM; Gourbali V; Johnson J; Papakonstantinou I; Papadimitriou A; Singleton AB
    Eur J Neurol; 2007 Jan; 14(1):7-11. PubMed ID: 17222106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
    Bandrés-Ciga S; Mencacci NE; Durán R; Barrero FJ; Escamilla-Sevilla F; Morgan S; Hehir J; Vives F; Hardy J; Pittman AM
    Neurobiol Aging; 2016 Jan; 37():210.e1-210.e5. PubMed ID: 26518746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the Role of SNCA, LRRK2, and GBA in Chinese Patients With Early-Onset Parkinson's Disease.
    Chen Y; Gu X; Ou R; Zhang L; Hou Y; Liu K; Cao B; Wei Q; Li C; Song W; Zhao B; Wu Y; Cheng J; Shang H
    Mov Disord; 2020 Nov; 35(11):2046-2055. PubMed ID: 32677286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.